Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
70 Cards in this Set
- Front
- Back
which chemo drugs act as alkylating agents
|
cyclophosphamide
mechlorethamine cisplastin carboplastin carmustine lomustine procarbazine busulfan |
|
major SE of cyclophosphamide
|
hemorrhagic cystitis
|
|
pretreatment for the potential SE of cyclophosphamide
|
MESNA
|
|
difference in SE between cisplastin and carboplastin
|
cisplastin: more severe nephro/ototoxicity
carboplastin: more severe myelosuppression |
|
DOC for brain tumors
|
nitrosoureas (lomustine or carmustine)
|
|
produces a disulfiram-like reaction when combined with alcohol
|
procarbazine
|
|
2 chemo drugs with a SE of pulmonary fibrosis
|
bleomycin and busulfan
(*note that busulfan also has hyperpigmentation) |
|
MOA of methotrexate
|
inhibits dihydrofolate reductase
|
|
DOC to reverse potential SE of methotrexate
|
leucovorin
|
|
SE of methotrexate
|
myelosuppression, fatty liver, mucositis
|
|
what non-cancer conditions can methotrexate also be used for
|
ectopic pregnancies
rheumatoid arthritis psoriasis |
|
MOA of 6-MP
|
blocks de novo purine synthesis
|
|
DOC for AML
|
6-MP
|
|
enzyme required for activation of 6-MP
|
HGPRT
|
|
gout drug that when combined with 6MP requires dose reduction
|
allopurinol
|
|
MOA of 5-FU
|
inhibits thymidylate synthase
|
|
drug that causes "thymine-less death" when given with leucovorin rescue
|
5-FU
|
|
chemo drug that is very effective against colon cancer and basal cell carcinoma
|
5-FU
|
|
MOA of cytarabine
|
blocks DNA polymerase
|
|
difference in the MOA of vincristine/vinblastine vs. paclitaxel
|
vincristine/vinblastine: bind specifically to B-tubulin and block polymerization of the microtubules thus preventing the formation of the mitotic spindle
paclitaxel: stabilizes microtubule formation leading to disassembly with the cells arrested in mitosis (metaphase) |
|
which phase of mitosis due cells remain frozen in when given paclitaxel
|
frozen in metaphase
|
|
2 main cancers that paclitaxel is used to treat
|
breast and ovarian cancer
|
|
MOA of doxorubicin
|
inhibits topoisomerase II and forms free radicals which cause DNA strand breaks
|
|
major SE of doxorubicin
|
cardiomyopathy
|
|
DOC to prevent the major SE associated with doxorubicin
|
dexrazoxane
|
|
DOC for Wilms tumor, Ewing sarcoma, and rhabdomyosarcomas
|
dactinomycin
|
|
MOA of bleomycin
|
causes breaks in the DNA strands via free radical formation ("scissision" and "fragmentation")
|
|
this drug has the same MOA as bleomycin but does NOT cause pulmonary fibrosis, but rather SEVERE myelosuppression
|
mitomycin
|
|
MOA of imatinib
|
inhibits bcr-abl tyrosine kinase
|
|
DOC for CML and GIST tumors
|
imatinib
|
|
MOA of rituximab
|
forms monoclonal antibodies against CD20
|
|
MOA of trastuzumab
|
blocks binding to the HER-2/neu growth receptor
|
|
DOC to treat estrogen-positive breast cancer
|
tamoxifen
|
|
SE of tamoxifen
|
increases risk for endometrial cancer
thromboembolisms hot flashes |
|
similar drug to tamoxifen that is used in the advanced stages of breast cancer (stage 4)
|
toremifene
|
|
chemo drug that in addition to treating breast cancer, can also treat osteoporosis
|
raloxifene
|
|
acts by blocking the pituitary's secretion of gonadotropins to induce ovulation
|
clomiphene
|
|
aromatase inhibitor used in breast cancer
|
anastrozole and letrozole
|
|
MOA of bevacizumab
|
blocks the binding of VEGF to its receptors
|
|
MOA of hydroxyurea
|
inhibits ribonucleotide reductase
|
|
which cell cycle phase is hydroxyurea specific for
|
S-phase
|
|
non-cancer condition that hydroxyurea is used in
|
sickle cell
|
|
2 major cancers that hydoxyurea is used for
|
melanoma and CML
|
|
major SE of L-asparaginase
|
acute pancreatitis
|
|
MOA of L-asparaginase
|
converts asparagine to aspartate thus denying cancer cells of the essential amino acid- asparagine
|
|
DOC in prostate cancer
|
flutamide
|
|
MOA of flutamide
|
blocks androgen receptors
|
|
4 drug combination used commonly in testicular cancer
|
bleomycin
vinblastine etoposide cisplastin ("BVEC") |
|
5 drug combination used commonly in Non-Hodgkin's lymphoma
|
cyclophosphamide
doxorubicin vincristine rituximab prednisone (*note this is the CHOP regimen) |
|
4 drug combination used commonly in most breast cancers
|
5-FU
cyclophosphamide methotrexate tamoxifen ("5-CMT") |
|
which chemo drugs are cell cycle specific (CCS)
|
bleomycin
vincristine/vinblastine 5-FU 6-MP methotrexate etoposide |
|
which chemo drugs are cell cycle non-specific (CCNS)
|
all alkylating agents
doxorubicin nitrosoureas |
|
chemo drugs that are cell cycle specific act on tumor cells throughout all stages of the cell cycle EXCEPT which one?
|
G0 phase
|
|
what is the growth fraction
|
proportion of tumor cells that are "actively" dividing
|
|
how often is pulse therapy given
|
every 3-4 weeks
|
|
what's the log-kill hypothesis
|
when giving chemo, a constant proportion of the tumor cell population is killed rather than a constant number
|
|
difference between the grading and staging of a cancer, and which one is more important to the prognosis
|
grading: degree of differentiation
staging: degree of spread (metastasis) *staging is more prognostic |
|
what cancer is cytarabine typically used for
|
various leukemias
|
|
SE of vincristine/vinblastine
|
neurotoxicity
peripheral neuropathies foot drop paralytic ileus myelosuppression SIADH |
|
3 major cancers that vinblastine/vincristine is used against
|
Hodgkin's lymphoma, Wilms tumor, and choriocarcinoma
|
|
MOA of etoposide
|
inhibits topoisomerase II
|
|
SE of paclitaxel
|
myelosuppression and peripheral neuropathies
|
|
this chemo drug has a side effect of cerebellar dysfunction
|
cytarabine
|
|
gene mutation expressed by many cancers which provides resistance to various chemo treatments
|
MDR1 gene
|
|
chemo DOC for insulinomas
|
streptozocin
|
|
what 4 chemo drugs make up the MOPP regimen
|
mechlorethamine
vincristine prednisone procarbazine |
|
what 4 chemo drugs make up the ABVD regimen
|
doxorubicin
bleomycin vinblastine dacarbazine |
|
what cancer is the ABVD regimen typically used in
|
Hodgkin's lymphoma
|
|
what 5 chemo drugs make up the CHOP regimen
|
cyclophosphamide
doxorubicin vincristine rituximab prednisone |
|
what cancer is the CHOP regimen typically used for
|
Non-Hodgkin's lymphoma
|